MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-14-2024
Acutus Medical DIO Ratio 2011-2026 | AFIB
Annual DIO Ratio Acutus Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108 | 672 | 163 | 298 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 672 | 108 | 310 |
Quarterly DIO Ratio Acutus Medical
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87.7 | 113 | 127 | - | 455 | 553 | 611 | - | 196 | 155 | 224 | - | 158 | 174 | 176 | - | 230 | 444 | 305 | - | 339 | 158 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 611 | 87.7 | 265 |
DIO Ratio of other stocks in the Medical devices industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Allied Healthcare Products
AHPI
|
133 | - | 3.58 % | $ 2.21 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
75.1 | - | - | $ 1.77 B | USA |
 |
Lianluo Smart Limited
LLIT
|
50 | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
240 | - | -5.86 % | $ 30.6 M | USA |
 |
Avinger
AVGR
|
332 | - | -20.74 % | $ 369 K | USA |
 |
Aziyo Biologics
AZYO
|
146 | - | 1.37 % | $ 20.5 M | USA |
 |
Alphatec Holdings
ATEC
|
271 | $ 12.53 | -0.24 % | $ 1.88 B | USA |
 |
Cutera
CUTR
|
135 | - | -10.19 % | $ 1.99 M | USA |
 |
BIOLASE
BIOL
|
154 | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
160 | - | - | $ 16.4 M | USA |
 |
AxoGen
AXGN
|
238 | $ 30.51 | -1.39 % | $ 1.4 B | USA |
 |
Apollo Endosurgery
APEN
|
160 | - | - | $ 475 M | USA |
 |
CryoLife, Inc.
CRY
|
312 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
247 | - | 1.15 % | $ 34.5 M | USA |
 |
Dynatronics Corporation
DYNT
|
91.1 | - | 14.99 % | $ 929 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
290 | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
143 | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
212 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
272 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
10.1 | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
145 | - | - | $ 955 M | USA |
 |
AdaptHealth Corp.
AHCO
|
20.2 | $ 9.98 | -4.68 % | $ 1.35 B | USA |
 |
BioSig Technologies
BSGM
|
7.1 K | - | 37.08 % | $ 85.7 M | USA |
 |
Second Sight Medical Products
EYES
|
175 | - | -0.97 % | $ 54.4 M | USA |
 |
Invacare Corporation
IVC
|
82.8 | - | - | $ 24.7 M | USA |
 |
Butterfly Network
BFLY
|
790 | $ 3.91 | -1.01 % | $ 828 M | USA |
 |
Align Technology
ALGN
|
83.8 | $ 176.5 | 2.37 % | $ 13.2 B | USA |
 |
Bio-Rad Laboratories
BIO
|
237 | $ 264.66 | -1.24 % | $ 7.47 B | USA |
 |
Bruker Corporation
BRKR
|
216 | $ 33.66 | -1.09 % | $ 5.02 K | USA |
 |
Boston Scientific Corporation
BSX
|
169 | $ 70.61 | -0.94 % | $ 105 B | USA |
 |
ClearPoint Neuro
CLPT
|
195 | $ 9.07 | -5.57 % | $ 257 M | USA |
 |
CONMED Corporation
CNMD
|
205 | $ 36.35 | -0.98 % | $ 1.13 B | USA |
 |
Cardiovascular Systems
CSII
|
192 | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
106 | $ 0.61 | -6.83 % | $ 33.2 M | USA |
 |
Delcath Systems
DCTH
|
266 | $ 9.35 | -0.37 % | $ 335 M | USA |
 |
Inari Medical
NARI
|
220 | - | - | $ 4.23 B | USA |
 |
EDAP TMS S.A.
EDAP
|
163 | $ 3.77 | -3.83 % | $ 141 M |  France |
 |
Electromed
ELMD
|
91.2 | $ 23.25 | 0.33 % | $ 197 M | USA |
 |
Eargo
EAR
|
85.3 | - | - | $ 10.2 M | USA |
 |
Establishment Labs Holdings
ESTA
|
463 | $ 65.47 | -0.05 % | $ 1.94 B |  Costa-rica |
 |
Edwards Lifesciences Corporation
EW
|
303 | $ 82.65 | 0.05 % | $ 48.3 B | USA |
 |
FONAR Corporation
FONR
|
13.9 | $ 18.41 | -0.19 % | $ 121 M | USA |
 |
NuVasive
NUVA
|
355 | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
291 | - | - | $ 217 M | USA |
 |
Globus Medical
GMED
|
270 | $ 85.71 | -1.0 % | $ 11.6 B | USA |
 |
Helius Medical Technologies
HSDT
|
327 | $ 2.1 | 1.35 % | $ 1.28 M | USA |